United States Viral Vector Manufacturing Market Set for Strong Growth Driven by Gene Therapy Advancements 2025 | Top key players - Sanofi SA, CGT Catapult, UniQure NV.

Market Size and Growth:

The Viral Vector Manufacturing Market size reached USD 0.9 billion in 2022 and is expected to reach USD 3.8 billion by 2031 growing with a CAGR of 20.3% during the forecast period 2024-2031.

The Viral Vector Manufacturing Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/viral-vector-manufacturing-market?sz

The Viral Vector Manufacturing Market refers to the industry focused on producing viral vectors, which are engineered viruses used to deliver genetic material into cells. These vectors are critical in gene therapy, cell therapy, and vaccine development. The market encompasses contract manufacturing, in-house production, and advanced technologies to ensure safe, scalable, and efficient vector supply for biopharmaceutical applications.

Recent Key Developments of United States and Japan:

USA:
August 2025: A leading CDMO, ProBio, launched cGMP Adeno-Associated Virus (AAV) manufacturing services at its state-of-the-art facility in Hopewell, New Jersey, expanding domestic capacity for gene therapy vectors.

July 2025: 4D Molecular Therapeutics announced a workforce reduction while fast-tracking its Phase 3 gene therapy program using its customized AAV vectors, signaling a strategic focus on late-stage clinical manufacturing.

July 2025: Myrtelle Inc. established commercial-stage manufacturing for its oligotrophic recombinant AAV product (MYR-101) for Canavan disease, marking the transition to market supply-readiness for a new gene therapy candidate.

Japan:
September 2025: Takeda Pharmaceutical launched a novel AAV-based gene therapy for rare metabolic disorders, driving demand for commercial-scale AAV vector production.

August 2025: Mitsubishi Tanabe Pharma invested a significant sum (¥15 billion) in a new gene therapy manufacturing facility in Osaka, specifically focusing on viral vector production for domestic and regional clinical trials.

July 2025: Ono Pharmaceutical partnered with universities to advance CRISPR-based gene editing therapies, which often rely on viral vectors (like AAV or lentivirus) for gene delivery, accelerating preclinical vector R&D.

List of the Key Players in the Viral Vector Manufacturing Market:

Sanofi SA
Thermo Fisher Scientific Inc.
Cobra Biologics Ltd
Lonza Group Ltd
Merck & Co.
Oxford BioMedica
CGT Catapult
UniQure NV
FUJIFILM Diosynth Biotechnologies
Spark Therapeutics Inc.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/viral-vector-manufacturing-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Viral Vector Manufacturing Market:

By Type: Retroviral Vectors, Adenoviral Vectors, Adeno-Associated Viral Vectors, Other Viral Vectors.

By Disease: Cancer, Genetic Disorders, Infectious Diseases, Other Diseases.

By Application: Gene Therapy, Vaccinology.

By End User: Pharmaceutical and Biopharmaceutical Companies, Research Institutes.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=viral-vector-manufacturing-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Viral Vector Manufacturing market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Viral Vector Manufacturing Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Viral Vector Manufacturing market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Viral Vector Manufacturing Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Viral Vector Manufacturing Market in 2025?
◆ What is the projected growth rate of the Viral Vector Manufacturing Market through 2033?
◆ Who are the key players in the Viral Vector Manufacturing Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.